Actively Recruiting
Diagnosis and OutcoMes evaluAtIoN of Multicenter Patients With HFpEF Using Multimodality Imaging
Led by Chinese Academy of Medical Sciences, Fuwai Hospital · Updated on 2022-04-18
1000
Participants Needed
1
Research Sites
395 weeks
Total Duration
On this page
Sponsors
C
Chinese Academy of Medical Sciences, Fuwai Hospital
Lead Sponsor
P
Peking Union Medical College Hospital
Collaborating Sponsor
AI-Summary
What this Trial Is About
The incidence of Heart failure with preserved ejection fraction (HFpEF) in Heart failure patients increases rapidly. However, the current clinical awareness is insufficient, and the cardiac structural and functional injury are not well understood. It is difficult to recognize the subclinical changes of the cardiac in the early stage with conventional imaging techniques, and it is common to ignore the existence of the clinical alterations. This study aimed to investigate the cardiac features, early diagnosis and risk factors of HFpEF patients, based on the multi-modality (Magnetic resonance imaging- nuclear medicine imaging- echocardiography) imaging and multicenter study, combined with large data and artificial intelligence. This study will provide deep insights into the HFpEF in multicenter population.
CONDITIONS
Official Title
Diagnosis and OutcoMes evaluAtIoN of Multicenter Patients With HFpEF Using Multimodality Imaging
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Left ventricular ejection fraction (LVEF) 50% or higher
- N-terminal pro-b type natriuretic peptide (NT-proBNP) above 220 pg/ml or b type natriuretic peptide (BNP) above 80 pg/ml
- Presence of symptoms and syndromes of heart failure
- At least one abnormality in cardiac structure (left ventricular hypertrophy or left atrial enlargement) or function based on tissue Doppler or color Doppler
You will not qualify if you...
- Having special types of cardiomyopathy such as hypertrophic or restrictive cardiomyopathy
- Infarction or myocardial fibrosis caused by ischemic cardiomyopathy or acute coronary syndrome
- Severe arrhythmia
- Severe primary cardiac valvular disease
- Restrictive pericardial disease
- Refusal to participate in the study
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Fuwai Hospital
Beijing, Beijing Municipality, China, 100037
Actively Recruiting
Research Team
M
Minjie Lu, PhD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here